Anxiety Disorders - Pipeline Review, H1 2015

1
Anxiety Disorders - Pipeline Review, H1 2015
2
Report Description
Summary Global Markets Directs, Anxiety
Disorders - Pipeline Review, H1 2015, provides
an overview of the Anxiety Disorderss
therapeutic pipeline. This report provides
comprehensive information on the therapeutic
development for Anxiety Disorders, complete with
comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type, along with latest updates, and
featured news and press releases. It also reviews
key players involved in the therapeutic
development for Anxiety Disorders and special
features on late-stage and discontinued
projects. Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team.
Get More About This Report At
http//www.bigmarketresearch.com/anxiety-disorders
-pipeline-review-h1-2015-market
3
Report Description
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Enquire About This Report
At http//www.bigmarketresearch.com/report-enquir
y/182183
4
Report Description
Scope - The report provides a snapshot of the
global therapeutic landscape of Anxiety
Disorders - The report reviews key pipeline
products under drug profile section which
includes, product description, MoA and RD brief,
licensing and collaboration details other
developmental activities - The report reviews
key players involved in the therapeutics
development for Anxiety Disorders and enlists all
their major and minor projects - The report
summarizes all the dormant and discontinued
pipeline projects - A review of the Anxiety
Disorders products under development by companies
and universities/research institutes based on
information derived from company and
industry-specific sources - Pipeline products
coverage based on various stages of development
ranging from pre-registration till discovery and
undisclosed stages - A detailed assessment of
monotherapy and combination therapy pipeline
projects - Coverage of the Anxiety Disorders
pipeline on the basis of target, MoA, route of
administration and molecule type - Latest news
and deals relating related to pipeline products
5
Report Description
Reasons to buy - Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies - Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage - Develop strategic initiatives by
understanding the focus areas of leading
companies - Identify and understand important and
diverse types of therapeutics under development
for Anxiety Disorders - Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline - Devise
corrective measures for pipeline projects by
understanding Anxiety Disorders pipeline depth
and focus of Indication therapeutics - Develop
and design in-licensing and out-licensing
strategies by identifying prospective partners
with the most attractive projects to enhance and
expand business potential and scope - Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline
6
Table Of Contents
Chapter one Introduction Chapter two Global
Markets Direct Report Coverage Chapter three
Anxiety Disorders Overview Chapter four
Therapeutics Development Chapter five Pipeline
Products for Anxiety Disorders - Overview Chapter
six Anxiety Disorders - Therapeutics under
Development by Companies Chapter seven Clinical
Stage Products Chapter Eight Early Stage
Products Chapter Nine Unknown Stage
Products Get Complete TOC at
http//www.bigmarketresearch.com/anxiety-disorders
-pipeline-review-h1-2015-market
7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/anxiety-disorders
-pipeline-review-h1-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
sales_at_bigmarketresearch.com